ロード中...

PD-L1 expression as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma

Cytokine-induced killer (CIK) cell immunotherapy represents an effective treatment strategy for treating hepatocellular carcinoma (HCC). However, the therapeutic benefits of CIK cell treatment can be influenced by differences in complex immune microenvironment between patients. Herein, we investigat...

詳細記述

保存先:
書誌詳細
出版年:Oncoimmunology
主要な著者: Chen, Chang-Long, Pan, Qiu-Zhong, Zhao, Jing-Jing, Wang, Ying, Li, Yong-Qiang, Wang, Qi-Jing, Pan, Ke, Weng, De-Sheng, Jiang, Shan-Shan, Tang, Yan, Zhang, Xiao-Fei, Zhang, Hong-Xia, Zhou, Zi-Qi, Zeng, Yi-Xin, Xia, Jian-Chuan
フォーマット: Artigo
言語:Inglês
出版事項: Taylor & Francis 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5006896/
https://ncbi.nlm.nih.gov/pubmed/27622026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1176653
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!